nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivaroxaban—ABCB1—Mitomycin—stomach cancer	0.201	0.363	CbGbCtD
Rivaroxaban—CYP3A5—Irinotecan—stomach cancer	0.0791	0.143	CbGbCtD
Rivaroxaban—CYP3A5—Docetaxel—stomach cancer	0.058	0.105	CbGbCtD
Rivaroxaban—ABCB1—Irinotecan—stomach cancer	0.0515	0.0932	CbGbCtD
Rivaroxaban—ABCB1—Docetaxel—stomach cancer	0.0377	0.0683	CbGbCtD
Rivaroxaban—CYP3A4—Irinotecan—stomach cancer	0.0308	0.0558	CbGbCtD
Rivaroxaban—ABCB1—Doxorubicin—stomach cancer	0.0281	0.0509	CbGbCtD
Rivaroxaban—ABCB1—Methotrexate—stomach cancer	0.0272	0.0493	CbGbCtD
Rivaroxaban—CYP3A4—Docetaxel—stomach cancer	0.0226	0.0409	CbGbCtD
Rivaroxaban—CYP3A4—Doxorubicin—stomach cancer	0.0168	0.0305	CbGbCtD
Rivaroxaban—CYP2J2—blood vessel—stomach cancer	0.00636	0.197	CbGeAlD
Rivaroxaban—F10—hematopoietic system—stomach cancer	0.00413	0.128	CbGeAlD
Rivaroxaban—F10—endocrine gland—stomach cancer	0.00237	0.0735	CbGeAlD
Rivaroxaban—F10—liver—stomach cancer	0.00214	0.0663	CbGeAlD
Rivaroxaban—CYP2J2—endocrine gland—stomach cancer	0.00195	0.0603	CbGeAlD
Rivaroxaban—CYP2J2—liver—stomach cancer	0.00175	0.0543	CbGeAlD
Rivaroxaban—F10—lymph node—stomach cancer	0.00164	0.0508	CbGeAlD
Rivaroxaban—CYP3A5—hematopoietic system—stomach cancer	0.00119	0.0369	CbGeAlD
Rivaroxaban—ABCB1—blood vessel—stomach cancer	0.00119	0.0368	CbGeAlD
Rivaroxaban—CYP3A5—pancreas—stomach cancer	0.00097	0.0301	CbGeAlD
Rivaroxaban—CYP3A4—hematopoietic system—stomach cancer	0.000894	0.0277	CbGeAlD
Rivaroxaban—CYP3A5—digestive system—stomach cancer	0.000828	0.0257	CbGeAlD
Rivaroxaban—CYP3A5—endocrine gland—stomach cancer	0.000685	0.0212	CbGeAlD
Rivaroxaban—ABCB1—hematopoietic system—stomach cancer	0.000633	0.0196	CbGeAlD
Rivaroxaban—CYP3A4—digestive system—stomach cancer	0.000622	0.0193	CbGeAlD
Rivaroxaban—CYP3A5—liver—stomach cancer	0.000617	0.0191	CbGeAlD
Rivaroxaban—ABCB1—epithelium—stomach cancer	0.000578	0.0179	CbGeAlD
Rivaroxaban—ABCB1—pancreas—stomach cancer	0.000515	0.016	CbGeAlD
Rivaroxaban—CYP3A4—endocrine gland—stomach cancer	0.000514	0.0159	CbGeAlD
Rivaroxaban—CYP3A4—liver—stomach cancer	0.000463	0.0143	CbGeAlD
Rivaroxaban—ABCB1—lymphoid tissue—stomach cancer	0.000446	0.0138	CbGeAlD
Rivaroxaban—ABCB1—digestive system—stomach cancer	0.00044	0.0136	CbGeAlD
Rivaroxaban—ABCB1—bone marrow—stomach cancer	0.000406	0.0126	CbGeAlD
Rivaroxaban—Hepatobiliary disease—Methotrexate—stomach cancer	0.00038	0.00134	CcSEcCtD
Rivaroxaban—Epistaxis—Methotrexate—stomach cancer	0.000379	0.00133	CcSEcCtD
Rivaroxaban—Hypersensitivity—Irinotecan—stomach cancer	0.000379	0.00133	CcSEcCtD
Rivaroxaban—Syncope—Capecitabine—stomach cancer	0.000378	0.00133	CcSEcCtD
Rivaroxaban—Infestation NOS—Epirubicin—stomach cancer	0.000376	0.00132	CcSEcCtD
Rivaroxaban—Infestation—Epirubicin—stomach cancer	0.000376	0.00132	CcSEcCtD
Rivaroxaban—Agranulocytosis—Methotrexate—stomach cancer	0.000375	0.00132	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Epirubicin—stomach cancer	0.000373	0.00131	CcSEcCtD
Rivaroxaban—Chest pain—Docetaxel—stomach cancer	0.000371	0.00131	CcSEcCtD
Rivaroxaban—Loss of consciousness—Capecitabine—stomach cancer	0.000371	0.00131	CcSEcCtD
Rivaroxaban—Renal failure—Epirubicin—stomach cancer	0.00037	0.0013	CcSEcCtD
Rivaroxaban—Asthenia—Irinotecan—stomach cancer	0.000369	0.0013	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000368	0.0013	CcSEcCtD
Rivaroxaban—Jaundice—Epirubicin—stomach cancer	0.000367	0.00129	CcSEcCtD
Rivaroxaban—Urinary tract infection—Epirubicin—stomach cancer	0.000366	0.00129	CcSEcCtD
Rivaroxaban—ABCB1—endocrine gland—stomach cancer	0.000364	0.0113	CbGeAlD
Rivaroxaban—Hypersensitivity—Fluorouracil—stomach cancer	0.000363	0.00128	CcSEcCtD
Rivaroxaban—Dry mouth—Docetaxel—stomach cancer	0.000363	0.00128	CcSEcCtD
Rivaroxaban—Haemoglobin—Methotrexate—stomach cancer	0.000363	0.00128	CcSEcCtD
Rivaroxaban—Hepatitis—Methotrexate—stomach cancer	0.000361	0.00127	CcSEcCtD
Rivaroxaban—Haemorrhage—Methotrexate—stomach cancer	0.000361	0.00127	CcSEcCtD
Rivaroxaban—Chest pain—Capecitabine—stomach cancer	0.000359	0.00126	CcSEcCtD
Rivaroxaban—Haematuria—Epirubicin—stomach cancer	0.000359	0.00126	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000357	0.00126	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Methotrexate—stomach cancer	0.000356	0.00125	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Epirubicin—stomach cancer	0.000356	0.00125	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Docetaxel—stomach cancer	0.000356	0.00125	CcSEcCtD
Rivaroxaban—Oedema—Docetaxel—stomach cancer	0.000356	0.00125	CcSEcCtD
Rivaroxaban—Discomfort—Capecitabine—stomach cancer	0.000355	0.00125	CcSEcCtD
Rivaroxaban—Epistaxis—Epirubicin—stomach cancer	0.000355	0.00125	CcSEcCtD
Rivaroxaban—Urethral disorder—Methotrexate—stomach cancer	0.000354	0.00125	CcSEcCtD
Rivaroxaban—Infection—Docetaxel—stomach cancer	0.000353	0.00124	CcSEcCtD
Rivaroxaban—Sinusitis—Epirubicin—stomach cancer	0.000353	0.00124	CcSEcCtD
Rivaroxaban—Diarrhoea—Irinotecan—stomach cancer	0.000352	0.00124	CcSEcCtD
Rivaroxaban—Dry mouth—Capecitabine—stomach cancer	0.000351	0.00124	CcSEcCtD
Rivaroxaban—Agranulocytosis—Epirubicin—stomach cancer	0.000351	0.00124	CcSEcCtD
Rivaroxaban—Shock—Docetaxel—stomach cancer	0.00035	0.00123	CcSEcCtD
Rivaroxaban—Nervous system disorder—Docetaxel—stomach cancer	0.000349	0.00123	CcSEcCtD
Rivaroxaban—Pruritus—Fluorouracil—stomach cancer	0.000349	0.00123	CcSEcCtD
Rivaroxaban—Infestation NOS—Doxorubicin—stomach cancer	0.000348	0.00123	CcSEcCtD
Rivaroxaban—Infestation—Doxorubicin—stomach cancer	0.000348	0.00123	CcSEcCtD
Rivaroxaban—Tachycardia—Docetaxel—stomach cancer	0.000347	0.00122	CcSEcCtD
Rivaroxaban—Skin disorder—Docetaxel—stomach cancer	0.000345	0.00122	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.000345	0.00121	CcSEcCtD
Rivaroxaban—Oedema—Capecitabine—stomach cancer	0.000344	0.00121	CcSEcCtD
Rivaroxaban—Renal failure—Doxorubicin—stomach cancer	0.000342	0.0012	CcSEcCtD
Rivaroxaban—Infection—Capecitabine—stomach cancer	0.000342	0.0012	CcSEcCtD
Rivaroxaban—Erythema multiforme—Methotrexate—stomach cancer	0.000341	0.0012	CcSEcCtD
Rivaroxaban—Dizziness—Irinotecan—stomach cancer	0.00034	0.0012	CcSEcCtD
Rivaroxaban—Haemoglobin—Epirubicin—stomach cancer	0.000339	0.00119	CcSEcCtD
Rivaroxaban—Jaundice—Doxorubicin—stomach cancer	0.000339	0.00119	CcSEcCtD
Rivaroxaban—Shock—Capecitabine—stomach cancer	0.000339	0.00119	CcSEcCtD
Rivaroxaban—Urinary tract infection—Doxorubicin—stomach cancer	0.000338	0.00119	CcSEcCtD
Rivaroxaban—Nervous system disorder—Capecitabine—stomach cancer	0.000338	0.00119	CcSEcCtD
Rivaroxaban—Haemorrhage—Epirubicin—stomach cancer	0.000338	0.00119	CcSEcCtD
Rivaroxaban—Hepatitis—Epirubicin—stomach cancer	0.000338	0.00119	CcSEcCtD
Rivaroxaban—Eye disorder—Methotrexate—stomach cancer	0.000337	0.00119	CcSEcCtD
Rivaroxaban—Diarrhoea—Fluorouracil—stomach cancer	0.000337	0.00119	CcSEcCtD
Rivaroxaban—Tachycardia—Capecitabine—stomach cancer	0.000336	0.00118	CcSEcCtD
Rivaroxaban—Cardiac disorder—Methotrexate—stomach cancer	0.000335	0.00118	CcSEcCtD
Rivaroxaban—Skin disorder—Capecitabine—stomach cancer	0.000334	0.00118	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Epirubicin—stomach cancer	0.000333	0.00117	CcSEcCtD
Rivaroxaban—Hypotension—Docetaxel—stomach cancer	0.000332	0.00117	CcSEcCtD
Rivaroxaban—Haematuria—Doxorubicin—stomach cancer	0.000332	0.00117	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Epirubicin—stomach cancer	0.000332	0.00117	CcSEcCtD
Rivaroxaban—Urethral disorder—Epirubicin—stomach cancer	0.000331	0.00117	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000329	0.00116	CcSEcCtD
Rivaroxaban—Epistaxis—Doxorubicin—stomach cancer	0.000328	0.00116	CcSEcCtD
Rivaroxaban—ABCB1—liver—stomach cancer	0.000328	0.0102	CbGeAlD
Rivaroxaban—Angiopathy—Methotrexate—stomach cancer	0.000327	0.00115	CcSEcCtD
Rivaroxaban—Vomiting—Irinotecan—stomach cancer	0.000327	0.00115	CcSEcCtD
Rivaroxaban—Sinusitis—Doxorubicin—stomach cancer	0.000326	0.00115	CcSEcCtD
Rivaroxaban—Immune system disorder—Methotrexate—stomach cancer	0.000326	0.00115	CcSEcCtD
Rivaroxaban—Dizziness—Fluorouracil—stomach cancer	0.000326	0.00115	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Methotrexate—stomach cancer	0.000325	0.00114	CcSEcCtD
Rivaroxaban—Agranulocytosis—Doxorubicin—stomach cancer	0.000325	0.00114	CcSEcCtD
Rivaroxaban—Rash—Irinotecan—stomach cancer	0.000324	0.00114	CcSEcCtD
Rivaroxaban—Dermatitis—Irinotecan—stomach cancer	0.000324	0.00114	CcSEcCtD
Rivaroxaban—Headache—Irinotecan—stomach cancer	0.000322	0.00113	CcSEcCtD
Rivaroxaban—Hypotension—Capecitabine—stomach cancer	0.000322	0.00113	CcSEcCtD
Rivaroxaban—Erythema multiforme—Epirubicin—stomach cancer	0.000319	0.00112	CcSEcCtD
Rivaroxaban—Dyspnoea—Docetaxel—stomach cancer	0.000317	0.00112	CcSEcCtD
Rivaroxaban—Eye disorder—Epirubicin—stomach cancer	0.000316	0.00111	CcSEcCtD
Rivaroxaban—Haemoglobin—Doxorubicin—stomach cancer	0.000314	0.00111	CcSEcCtD
Rivaroxaban—Cardiac disorder—Epirubicin—stomach cancer	0.000313	0.0011	CcSEcCtD
Rivaroxaban—Vomiting—Fluorouracil—stomach cancer	0.000313	0.0011	CcSEcCtD
Rivaroxaban—Dyspepsia—Docetaxel—stomach cancer	0.000313	0.0011	CcSEcCtD
Rivaroxaban—Haemorrhage—Doxorubicin—stomach cancer	0.000312	0.0011	CcSEcCtD
Rivaroxaban—Hepatitis—Doxorubicin—stomach cancer	0.000312	0.0011	CcSEcCtD
Rivaroxaban—Rash—Fluorouracil—stomach cancer	0.000311	0.00109	CcSEcCtD
Rivaroxaban—Dermatitis—Fluorouracil—stomach cancer	0.00031	0.00109	CcSEcCtD
Rivaroxaban—Headache—Fluorouracil—stomach cancer	0.000309	0.00109	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Doxorubicin—stomach cancer	0.000309	0.00109	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000307	0.00108	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Doxorubicin—stomach cancer	0.000307	0.00108	CcSEcCtD
Rivaroxaban—Dyspnoea—Capecitabine—stomach cancer	0.000307	0.00108	CcSEcCtD
Rivaroxaban—Fatigue—Docetaxel—stomach cancer	0.000307	0.00108	CcSEcCtD
Rivaroxaban—Angiopathy—Epirubicin—stomach cancer	0.000306	0.00108	CcSEcCtD
Rivaroxaban—Urethral disorder—Doxorubicin—stomach cancer	0.000306	0.00108	CcSEcCtD
Rivaroxaban—Nausea—Irinotecan—stomach cancer	0.000306	0.00108	CcSEcCtD
Rivaroxaban—Immune system disorder—Epirubicin—stomach cancer	0.000305	0.00107	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Epirubicin—stomach cancer	0.000304	0.00107	CcSEcCtD
Rivaroxaban—Pain—Docetaxel—stomach cancer	0.000304	0.00107	CcSEcCtD
Rivaroxaban—Constipation—Docetaxel—stomach cancer	0.000304	0.00107	CcSEcCtD
Rivaroxaban—Back pain—Methotrexate—stomach cancer	0.000304	0.00107	CcSEcCtD
Rivaroxaban—Dyspepsia—Capecitabine—stomach cancer	0.000303	0.00107	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000297	0.00105	CcSEcCtD
Rivaroxaban—Fatigue—Capecitabine—stomach cancer	0.000297	0.00105	CcSEcCtD
Rivaroxaban—Erythema multiforme—Doxorubicin—stomach cancer	0.000295	0.00104	CcSEcCtD
Rivaroxaban—Pain—Capecitabine—stomach cancer	0.000294	0.00104	CcSEcCtD
Rivaroxaban—Constipation—Capecitabine—stomach cancer	0.000294	0.00104	CcSEcCtD
Rivaroxaban—Feeling abnormal—Docetaxel—stomach cancer	0.000293	0.00103	CcSEcCtD
Rivaroxaban—Nausea—Fluorouracil—stomach cancer	0.000293	0.00103	CcSEcCtD
Rivaroxaban—Eye disorder—Doxorubicin—stomach cancer	0.000292	0.00103	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Methotrexate—stomach cancer	0.000291	0.00103	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Docetaxel—stomach cancer	0.000291	0.00102	CcSEcCtD
Rivaroxaban—Anaemia—Methotrexate—stomach cancer	0.00029	0.00102	CcSEcCtD
Rivaroxaban—Cardiac disorder—Doxorubicin—stomach cancer	0.00029	0.00102	CcSEcCtD
Rivaroxaban—Back pain—Epirubicin—stomach cancer	0.000284	0.001	CcSEcCtD
Rivaroxaban—Feeling abnormal—Capecitabine—stomach cancer	0.000284	0.000999	CcSEcCtD
Rivaroxaban—Angiopathy—Doxorubicin—stomach cancer	0.000283	0.000998	CcSEcCtD
Rivaroxaban—Malaise—Methotrexate—stomach cancer	0.000283	0.000997	CcSEcCtD
Rivaroxaban—Muscle spasms—Epirubicin—stomach cancer	0.000283	0.000995	CcSEcCtD
Rivaroxaban—Immune system disorder—Doxorubicin—stomach cancer	0.000282	0.000994	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Capecitabine—stomach cancer	0.000282	0.000991	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Doxorubicin—stomach cancer	0.000282	0.000991	CcSEcCtD
Rivaroxaban—Abdominal pain—Docetaxel—stomach cancer	0.000281	0.00099	CcSEcCtD
Rivaroxaban—Urticaria—Capecitabine—stomach cancer	0.000274	0.000963	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Epirubicin—stomach cancer	0.000273	0.00096	CcSEcCtD
Rivaroxaban—Abdominal pain—Capecitabine—stomach cancer	0.000272	0.000958	CcSEcCtD
Rivaroxaban—Anaemia—Epirubicin—stomach cancer	0.000272	0.000957	CcSEcCtD
Rivaroxaban—Chest pain—Methotrexate—stomach cancer	0.000267	0.000942	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000266	0.000935	CcSEcCtD
Rivaroxaban—Malaise—Epirubicin—stomach cancer	0.000265	0.000933	CcSEcCtD
Rivaroxaban—Discomfort—Methotrexate—stomach cancer	0.000264	0.00093	CcSEcCtD
Rivaroxaban—Syncope—Epirubicin—stomach cancer	0.000264	0.000928	CcSEcCtD
Rivaroxaban—Back pain—Doxorubicin—stomach cancer	0.000263	0.000926	CcSEcCtD
Rivaroxaban—Hypersensitivity—Docetaxel—stomach cancer	0.000262	0.000923	CcSEcCtD
Rivaroxaban—Muscle spasms—Doxorubicin—stomach cancer	0.000261	0.000921	CcSEcCtD
Rivaroxaban—Loss of consciousness—Epirubicin—stomach cancer	0.000258	0.00091	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Methotrexate—stomach cancer	0.000256	0.000903	CcSEcCtD
Rivaroxaban—Asthenia—Docetaxel—stomach cancer	0.000255	0.000899	CcSEcCtD
Rivaroxaban—Infection—Methotrexate—stomach cancer	0.000255	0.000897	CcSEcCtD
Rivaroxaban—Hypersensitivity—Capecitabine—stomach cancer	0.000254	0.000893	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Doxorubicin—stomach cancer	0.000252	0.000889	CcSEcCtD
Rivaroxaban—Pruritus—Docetaxel—stomach cancer	0.000252	0.000886	CcSEcCtD
Rivaroxaban—ABCB1—lymph node—stomach cancer	0.000251	0.00779	CbGeAlD
Rivaroxaban—Nervous system disorder—Methotrexate—stomach cancer	0.000251	0.000885	CcSEcCtD
Rivaroxaban—Anaemia—Doxorubicin—stomach cancer	0.000251	0.000885	CcSEcCtD
Rivaroxaban—Chest pain—Epirubicin—stomach cancer	0.00025	0.000881	CcSEcCtD
Rivaroxaban—Skin disorder—Methotrexate—stomach cancer	0.000249	0.000877	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000248	0.000875	CcSEcCtD
Rivaroxaban—Discomfort—Epirubicin—stomach cancer	0.000247	0.000871	CcSEcCtD
Rivaroxaban—Asthenia—Capecitabine—stomach cancer	0.000247	0.00087	CcSEcCtD
Rivaroxaban—Malaise—Doxorubicin—stomach cancer	0.000245	0.000864	CcSEcCtD
Rivaroxaban—Dry mouth—Epirubicin—stomach cancer	0.000245	0.000862	CcSEcCtD
Rivaroxaban—Syncope—Doxorubicin—stomach cancer	0.000244	0.000859	CcSEcCtD
Rivaroxaban—Pruritus—Capecitabine—stomach cancer	0.000244	0.000858	CcSEcCtD
Rivaroxaban—Diarrhoea—Docetaxel—stomach cancer	0.000243	0.000857	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Epirubicin—stomach cancer	0.00024	0.000845	CcSEcCtD
Rivaroxaban—Oedema—Epirubicin—stomach cancer	0.00024	0.000845	CcSEcCtD
Rivaroxaban—Hypotension—Methotrexate—stomach cancer	0.00024	0.000843	CcSEcCtD
Rivaroxaban—Loss of consciousness—Doxorubicin—stomach cancer	0.000239	0.000842	CcSEcCtD
Rivaroxaban—Infection—Epirubicin—stomach cancer	0.000238	0.000839	CcSEcCtD
Rivaroxaban—Shock—Epirubicin—stomach cancer	0.000236	0.000831	CcSEcCtD
Rivaroxaban—Diarrhoea—Capecitabine—stomach cancer	0.000236	0.00083	CcSEcCtD
Rivaroxaban—Nervous system disorder—Epirubicin—stomach cancer	0.000235	0.000828	CcSEcCtD
Rivaroxaban—Dizziness—Docetaxel—stomach cancer	0.000235	0.000828	CcSEcCtD
Rivaroxaban—Tachycardia—Epirubicin—stomach cancer	0.000234	0.000824	CcSEcCtD
Rivaroxaban—Skin disorder—Epirubicin—stomach cancer	0.000233	0.00082	CcSEcCtD
Rivaroxaban—Chest pain—Doxorubicin—stomach cancer	0.000232	0.000815	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.00023	0.00081	CcSEcCtD
Rivaroxaban—Discomfort—Doxorubicin—stomach cancer	0.000229	0.000806	CcSEcCtD
Rivaroxaban—Dyspnoea—Methotrexate—stomach cancer	0.000229	0.000805	CcSEcCtD
Rivaroxaban—Dizziness—Capecitabine—stomach cancer	0.000228	0.000802	CcSEcCtD
Rivaroxaban—Dry mouth—Doxorubicin—stomach cancer	0.000226	0.000797	CcSEcCtD
Rivaroxaban—Vomiting—Docetaxel—stomach cancer	0.000226	0.000796	CcSEcCtD
Rivaroxaban—Dyspepsia—Methotrexate—stomach cancer	0.000226	0.000795	CcSEcCtD
Rivaroxaban—Rash—Docetaxel—stomach cancer	0.000224	0.00079	CcSEcCtD
Rivaroxaban—Hypotension—Epirubicin—stomach cancer	0.000224	0.000789	CcSEcCtD
Rivaroxaban—Dermatitis—Docetaxel—stomach cancer	0.000224	0.000789	CcSEcCtD
Rivaroxaban—Headache—Docetaxel—stomach cancer	0.000223	0.000785	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Doxorubicin—stomach cancer	0.000222	0.000782	CcSEcCtD
Rivaroxaban—Oedema—Doxorubicin—stomach cancer	0.000222	0.000782	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000221	0.000779	CcSEcCtD
Rivaroxaban—Fatigue—Methotrexate—stomach cancer	0.000221	0.000778	CcSEcCtD
Rivaroxaban—Infection—Doxorubicin—stomach cancer	0.00022	0.000776	CcSEcCtD
Rivaroxaban—Pain—Methotrexate—stomach cancer	0.000219	0.000772	CcSEcCtD
Rivaroxaban—Vomiting—Capecitabine—stomach cancer	0.000219	0.000771	CcSEcCtD
Rivaroxaban—Shock—Doxorubicin—stomach cancer	0.000218	0.000769	CcSEcCtD
Rivaroxaban—Nervous system disorder—Doxorubicin—stomach cancer	0.000218	0.000766	CcSEcCtD
Rivaroxaban—Rash—Capecitabine—stomach cancer	0.000217	0.000764	CcSEcCtD
Rivaroxaban—Dermatitis—Capecitabine—stomach cancer	0.000217	0.000764	CcSEcCtD
Rivaroxaban—Tachycardia—Doxorubicin—stomach cancer	0.000217	0.000763	CcSEcCtD
Rivaroxaban—Headache—Capecitabine—stomach cancer	0.000216	0.00076	CcSEcCtD
Rivaroxaban—Skin disorder—Doxorubicin—stomach cancer	0.000216	0.000759	CcSEcCtD
Rivaroxaban—Dyspnoea—Epirubicin—stomach cancer	0.000214	0.000753	CcSEcCtD
Rivaroxaban—Nausea—Docetaxel—stomach cancer	0.000211	0.000744	CcSEcCtD
Rivaroxaban—Feeling abnormal—Methotrexate—stomach cancer	0.000211	0.000744	CcSEcCtD
Rivaroxaban—Dyspepsia—Epirubicin—stomach cancer	0.000211	0.000744	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Methotrexate—stomach cancer	0.00021	0.000738	CcSEcCtD
Rivaroxaban—Hypotension—Doxorubicin—stomach cancer	0.000207	0.00073	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000207	0.000729	CcSEcCtD
Rivaroxaban—Fatigue—Epirubicin—stomach cancer	0.000207	0.000728	CcSEcCtD
Rivaroxaban—Pain—Epirubicin—stomach cancer	0.000205	0.000722	CcSEcCtD
Rivaroxaban—Constipation—Epirubicin—stomach cancer	0.000205	0.000722	CcSEcCtD
Rivaroxaban—Nausea—Capecitabine—stomach cancer	0.000205	0.00072	CcSEcCtD
Rivaroxaban—Urticaria—Methotrexate—stomach cancer	0.000204	0.000717	CcSEcCtD
Rivaroxaban—Abdominal pain—Methotrexate—stomach cancer	0.000203	0.000714	CcSEcCtD
Rivaroxaban—Dyspnoea—Doxorubicin—stomach cancer	0.000198	0.000697	CcSEcCtD
Rivaroxaban—Feeling abnormal—Epirubicin—stomach cancer	0.000198	0.000696	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Epirubicin—stomach cancer	0.000196	0.000691	CcSEcCtD
Rivaroxaban—Dyspepsia—Doxorubicin—stomach cancer	0.000195	0.000688	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000192	0.000675	CcSEcCtD
Rivaroxaban—Fatigue—Doxorubicin—stomach cancer	0.000191	0.000674	CcSEcCtD
Rivaroxaban—Urticaria—Epirubicin—stomach cancer	0.000191	0.000671	CcSEcCtD
Rivaroxaban—Pain—Doxorubicin—stomach cancer	0.00019	0.000668	CcSEcCtD
Rivaroxaban—Constipation—Doxorubicin—stomach cancer	0.00019	0.000668	CcSEcCtD
Rivaroxaban—Abdominal pain—Epirubicin—stomach cancer	0.00019	0.000668	CcSEcCtD
Rivaroxaban—Hypersensitivity—Methotrexate—stomach cancer	0.000189	0.000665	CcSEcCtD
Rivaroxaban—Asthenia—Methotrexate—stomach cancer	0.000184	0.000648	CcSEcCtD
Rivaroxaban—Feeling abnormal—Doxorubicin—stomach cancer	0.000183	0.000644	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000181	0.000639	CcSEcCtD
Rivaroxaban—Pruritus—Methotrexate—stomach cancer	0.000181	0.000639	CcSEcCtD
Rivaroxaban—Hypersensitivity—Epirubicin—stomach cancer	0.000177	0.000622	CcSEcCtD
Rivaroxaban—Urticaria—Doxorubicin—stomach cancer	0.000176	0.000621	CcSEcCtD
Rivaroxaban—Abdominal pain—Doxorubicin—stomach cancer	0.000175	0.000618	CcSEcCtD
Rivaroxaban—Diarrhoea—Methotrexate—stomach cancer	0.000175	0.000618	CcSEcCtD
Rivaroxaban—Asthenia—Epirubicin—stomach cancer	0.000172	0.000606	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism—PDHA1—stomach cancer	0.00017	0.0013	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ECHS1—stomach cancer	0.00017	0.0013	CbGpPWpGaD
Rivaroxaban—Pruritus—Epirubicin—stomach cancer	0.00017	0.000598	CcSEcCtD
Rivaroxaban—Dizziness—Methotrexate—stomach cancer	0.000169	0.000597	CcSEcCtD
Rivaroxaban—ABCB1—Allograft Rejection—IL10—stomach cancer	0.000169	0.00129	CbGpPWpGaD
Rivaroxaban—Diarrhoea—Epirubicin—stomach cancer	0.000164	0.000578	CcSEcCtD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—stomach cancer	0.000164	0.00125	CbGpPWpGaD
Rivaroxaban—Hypersensitivity—Doxorubicin—stomach cancer	0.000164	0.000576	CcSEcCtD
Rivaroxaban—Vomiting—Methotrexate—stomach cancer	0.000163	0.000574	CcSEcCtD
Rivaroxaban—Rash—Methotrexate—stomach cancer	0.000162	0.000569	CcSEcCtD
Rivaroxaban—Dermatitis—Methotrexate—stomach cancer	0.000161	0.000569	CcSEcCtD
Rivaroxaban—Headache—Methotrexate—stomach cancer	0.000161	0.000565	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism—FADS1—stomach cancer	0.00016	0.00122	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—TYMP—stomach cancer	0.00016	0.00122	CbGpPWpGaD
Rivaroxaban—Asthenia—Doxorubicin—stomach cancer	0.000159	0.000561	CcSEcCtD
Rivaroxaban—Dizziness—Epirubicin—stomach cancer	0.000159	0.000559	CcSEcCtD
Rivaroxaban—Pruritus—Doxorubicin—stomach cancer	0.000157	0.000553	CcSEcCtD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—stomach cancer	0.000155	0.00118	CbGpPWpGaD
Rivaroxaban—Vomiting—Epirubicin—stomach cancer	0.000153	0.000537	CcSEcCtD
Rivaroxaban—Nausea—Methotrexate—stomach cancer	0.000152	0.000536	CcSEcCtD
Rivaroxaban—Diarrhoea—Doxorubicin—stomach cancer	0.000152	0.000535	CcSEcCtD
Rivaroxaban—Rash—Epirubicin—stomach cancer	0.000151	0.000533	CcSEcCtD
Rivaroxaban—Dermatitis—Epirubicin—stomach cancer	0.000151	0.000532	CcSEcCtD
Rivaroxaban—Headache—Epirubicin—stomach cancer	0.00015	0.000529	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism—SREBF2—stomach cancer	0.00015	0.00114	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—PLAU—stomach cancer	0.000149	0.00114	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—RORA—stomach cancer	0.000148	0.00113	CbGpPWpGaD
Rivaroxaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	0.000147	0.00112	CbGpPWpGaD
Rivaroxaban—Dizziness—Doxorubicin—stomach cancer	0.000147	0.000517	CcSEcCtD
Rivaroxaban—F10—Hemostasis—CAV1—stomach cancer	0.000146	0.00111	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—APOA1—stomach cancer	0.000146	0.00111	CbGpPWpGaD
Rivaroxaban—Nausea—Epirubicin—stomach cancer	0.000142	0.000502	CcSEcCtD
Rivaroxaban—Vomiting—Doxorubicin—stomach cancer	0.000141	0.000497	CcSEcCtD
Rivaroxaban—Rash—Doxorubicin—stomach cancer	0.00014	0.000493	CcSEcCtD
Rivaroxaban—Dermatitis—Doxorubicin—stomach cancer	0.00014	0.000492	CcSEcCtD
Rivaroxaban—Headache—Doxorubicin—stomach cancer	0.000139	0.00049	CcSEcCtD
Rivaroxaban—F10—Hemostasis—PRKCB—stomach cancer	0.000139	0.00106	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ALDOB—stomach cancer	0.000139	0.00106	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—stomach cancer	0.000134	0.00102	CbGpPWpGaD
Rivaroxaban—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—stomach cancer	0.000133	0.00101	CbGpPWpGaD
Rivaroxaban—Nausea—Doxorubicin—stomach cancer	0.000132	0.000464	CcSEcCtD
Rivaroxaban—CYP3A5—Biological oxidations—GSTP1—stomach cancer	0.000131	0.000998	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	0.000131	0.000997	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	0.000131	0.000994	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metapathway biotransformation—GSTP1—stomach cancer	0.000129	0.000985	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ALOX5—stomach cancer	0.000129	0.000983	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—DPYD—stomach cancer	0.000127	0.000967	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—stomach cancer	0.000126	0.000962	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—stomach cancer	0.000121	0.000919	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—GSTM1—stomach cancer	0.00012	0.000918	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metapathway biotransformation—GSTM1—stomach cancer	0.000119	0.000905	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—CASP8—stomach cancer	0.000117	0.000892	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—SERPINE1—stomach cancer	0.000116	0.000881	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—ALB—stomach cancer	0.000115	0.000879	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	0.000115	0.000876	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—stomach cancer	0.000115	0.000874	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ACAD8—stomach cancer	0.000113	0.000858	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GSTT1—stomach cancer	0.000112	0.000855	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—RHOA—stomach cancer	0.000112	0.00085	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CYP2A6—stomach cancer	0.000111	0.000845	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—NOS3—stomach cancer	0.00011	0.000841	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—AKR1C3—stomach cancer	0.000108	0.000822	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ENO1—stomach cancer	0.000105	0.000801	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—stomach cancer	0.000105	0.000799	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	0.000103	0.000788	CbGpPWpGaD
Rivaroxaban—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—stomach cancer	0.000101	0.000772	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GMPR2—stomach cancer	0.0001	0.000765	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—JUN—stomach cancer	9.94e-05	0.000757	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CD44—stomach cancer	9.32e-05	0.00071	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—MMP2—stomach cancer	9.27e-05	0.000706	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—CXCL8—stomach cancer	9.26e-05	0.000705	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—IDH3B—stomach cancer	9.19e-05	0.0007	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—SUCLG1—stomach cancer	9.19e-05	0.0007	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	9.05e-05	0.000689	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—IL1B—stomach cancer	8.88e-05	0.000677	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—GSTT1—stomach cancer	8.79e-05	0.00067	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—stomach cancer	8.76e-05	0.000667	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—CYP2A6—stomach cancer	8.69e-05	0.000662	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—VEGFA—stomach cancer	8.69e-05	0.000662	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—stomach cancer	8.61e-05	0.000656	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NDUFS1—stomach cancer	8.54e-05	0.000651	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NDUFV1—stomach cancer	8.54e-05	0.000651	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ACAD8—stomach cancer	8.5e-05	0.000648	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—stomach cancer	8.46e-05	0.000644	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—AKR1C3—stomach cancer	8.34e-05	0.000635	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—VEGFA—stomach cancer	7.95e-05	0.000606	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PPP2R1A—stomach cancer	7.93e-05	0.000604	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC1A2—stomach cancer	7.9e-05	0.000602	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GSTP1—stomach cancer	7.78e-05	0.000592	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—CXCL8—stomach cancer	7.7e-05	0.000587	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—HMOX1—stomach cancer	7.67e-05	0.000584	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PGLS—stomach cancer	7.61e-05	0.00058	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—BLVRB—stomach cancer	7.61e-05	0.00058	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GMPR2—stomach cancer	7.58e-05	0.000577	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—MAPK3—stomach cancer	7.52e-05	0.000573	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—VEGFA—stomach cancer	7.52e-05	0.000573	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PPAP2A—stomach cancer	7.26e-05	0.000553	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—TYMS—stomach cancer	7.23e-05	0.000551	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—MAPK1—stomach cancer	7.16e-05	0.000545	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GSTM1—stomach cancer	7.15e-05	0.000544	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—IDH3B—stomach cancer	6.93e-05	0.000528	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SUCLG1—stomach cancer	6.93e-05	0.000528	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—KRAS—stomach cancer	6.76e-05	0.000515	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ERCC2—stomach cancer	6.72e-05	0.000512	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—stomach cancer	6.59e-05	0.000502	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NDUFA2—stomach cancer	6.47e-05	0.000493	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CKB—stomach cancer	6.47e-05	0.000493	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—FBP1—stomach cancer	6.47e-05	0.000493	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CA1—stomach cancer	6.47e-05	0.000493	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—TNF—stomach cancer	6.45e-05	0.000491	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NDUFV1—stomach cancer	6.44e-05	0.000491	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NDUFS1—stomach cancer	6.44e-05	0.000491	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—MTHFR—stomach cancer	6.32e-05	0.000481	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—PIK3CA—stomach cancer	6.21e-05	0.000473	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	6.21e-05	0.000473	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—GSTP1—stomach cancer	6.09e-05	0.000464	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PLIN2—stomach cancer	6.09e-05	0.000464	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	6.01e-05	0.000458	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—TP53—stomach cancer	6.01e-05	0.000458	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CA2—stomach cancer	5.92e-05	0.000451	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CAV1—stomach cancer	5.83e-05	0.000444	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—APOA1—stomach cancer	5.81e-05	0.000443	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	5.78e-05	0.00044	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NT5E—stomach cancer	5.77e-05	0.000439	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PGAM1—stomach cancer	5.77e-05	0.000439	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—HRAS—stomach cancer	5.75e-05	0.000438	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PGLS—stomach cancer	5.74e-05	0.000438	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—BLVRB—stomach cancer	5.74e-05	0.000438	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—GSTM1—stomach cancer	5.6e-05	0.000427	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	5.57e-05	0.000424	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	5.52e-05	0.000421	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALDH7A1—stomach cancer	5.5e-05	0.000419	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PLCE1—stomach cancer	5.5e-05	0.000419	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PPAP2A—stomach cancer	5.48e-05	0.000417	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—UMPS—stomach cancer	5.28e-05	0.000402	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ACAD8—stomach cancer	5.24e-05	0.000399	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PPARG—stomach cancer	5.12e-05	0.00039	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PDHA1—stomach cancer	4.91e-05	0.000374	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ECHS1—stomach cancer	4.91e-05	0.000374	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CA1—stomach cancer	4.88e-05	0.000372	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NDUFA2—stomach cancer	4.88e-05	0.000372	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—FBP1—stomach cancer	4.88e-05	0.000372	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CKB—stomach cancer	4.88e-05	0.000372	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	4.82e-05	0.000367	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	4.71e-05	0.000359	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GMPR2—stomach cancer	4.67e-05	0.000356	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—FADS1—stomach cancer	4.61e-05	0.000351	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—TYMP—stomach cancer	4.61e-05	0.000351	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ALB—stomach cancer	4.61e-05	0.000351	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PLIN2—stomach cancer	4.59e-05	0.00035	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CA2—stomach cancer	4.47e-05	0.00034	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	4.46e-05	0.00034	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—NOS3—stomach cancer	4.41e-05	0.000336	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PGAM1—stomach cancer	4.35e-05	0.000332	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NT5E—stomach cancer	4.35e-05	0.000332	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—SREBF2—stomach cancer	4.32e-05	0.000329	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SUCLG1—stomach cancer	4.27e-05	0.000325	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—IDH3B—stomach cancer	4.27e-05	0.000325	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—RORA—stomach cancer	4.27e-05	0.000325	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	4.26e-05	0.000324	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	4.25e-05	0.000324	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALDH7A1—stomach cancer	4.15e-05	0.000316	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PLCE1—stomach cancer	4.15e-05	0.000316	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	4.12e-05	0.000314	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PTGS2—stomach cancer	4.03e-05	0.000307	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	4.02e-05	0.000306	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALDOB—stomach cancer	4e-05	0.000305	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—UMPS—stomach cancer	3.98e-05	0.000303	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NDUFV1—stomach cancer	3.97e-05	0.000302	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NDUFS1—stomach cancer	3.97e-05	0.000302	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALOX5—stomach cancer	3.72e-05	0.000283	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	3.71e-05	0.000283	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ECHS1—stomach cancer	3.7e-05	0.000282	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PDHA1—stomach cancer	3.7e-05	0.000282	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—DPYD—stomach cancer	3.66e-05	0.000279	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—HMOX1—stomach cancer	3.56e-05	0.000271	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PGLS—stomach cancer	3.54e-05	0.00027	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—BLVRB—stomach cancer	3.54e-05	0.00027	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	3.51e-05	0.000267	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—TYMP—stomach cancer	3.48e-05	0.000265	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—FADS1—stomach cancer	3.48e-05	0.000265	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	3.42e-05	0.00026	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPAP2A—stomach cancer	3.38e-05	0.000257	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	3.34e-05	0.000255	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	3.34e-05	0.000254	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SREBF2—stomach cancer	3.26e-05	0.000248	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTT1—stomach cancer	3.23e-05	0.000246	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—RORA—stomach cancer	3.22e-05	0.000245	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP2A6—stomach cancer	3.2e-05	0.000244	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	3.18e-05	0.000242	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	3.16e-05	0.00024	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—AKR1C3—stomach cancer	3.11e-05	0.000237	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ENO1—stomach cancer	3.03e-05	0.000231	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALDOB—stomach cancer	3.02e-05	0.00023	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NDUFA2—stomach cancer	3.01e-05	0.000229	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—FBP1—stomach cancer	3.01e-05	0.000229	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CKB—stomach cancer	3.01e-05	0.000229	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CA1—stomach cancer	3.01e-05	0.000229	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	2.9e-05	0.000221	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PLIN2—stomach cancer	2.83e-05	0.000216	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALOX5—stomach cancer	2.81e-05	0.000214	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	2.8e-05	0.000214	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—DPYD—stomach cancer	2.76e-05	0.00021	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CA2—stomach cancer	2.75e-05	0.00021	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	2.7e-05	0.000206	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CD44—stomach cancer	2.69e-05	0.000205	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NT5E—stomach cancer	2.68e-05	0.000204	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PGAM1—stomach cancer	2.68e-05	0.000204	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PLCE1—stomach cancer	2.56e-05	0.000195	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALDH7A1—stomach cancer	2.56e-05	0.000195	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PIK3CA—stomach cancer	2.48e-05	0.000189	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—UMPS—stomach cancer	2.45e-05	0.000187	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTT1—stomach cancer	2.44e-05	0.000186	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP2A6—stomach cancer	2.41e-05	0.000184	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—AKR1C3—stomach cancer	2.35e-05	0.000179	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ENO1—stomach cancer	2.29e-05	0.000174	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PPP2R1A—stomach cancer	2.29e-05	0.000174	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PDHA1—stomach cancer	2.28e-05	0.000174	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ECHS1—stomach cancer	2.28e-05	0.000174	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTP1—stomach cancer	2.24e-05	0.000171	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HMOX1—stomach cancer	2.21e-05	0.000168	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—FADS1—stomach cancer	2.14e-05	0.000163	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—TYMP—stomach cancer	2.14e-05	0.000163	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	2.14e-05	0.000163	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—TYMS—stomach cancer	2.08e-05	0.000159	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTM1—stomach cancer	2.06e-05	0.000157	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CD44—stomach cancer	2.03e-05	0.000154	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SREBF2—stomach cancer	2.01e-05	0.000153	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—RORA—stomach cancer	1.98e-05	0.000151	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ERCC2—stomach cancer	1.94e-05	0.000148	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALDOB—stomach cancer	1.86e-05	0.000142	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—MTHFR—stomach cancer	1.82e-05	0.000139	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALOX5—stomach cancer	1.73e-05	0.000132	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PPP2R1A—stomach cancer	1.72e-05	0.000131	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—DPYD—stomach cancer	1.7e-05	0.00013	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTP1—stomach cancer	1.69e-05	0.000129	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CAV1—stomach cancer	1.68e-05	0.000128	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—APOA1—stomach cancer	1.68e-05	0.000128	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HMOX1—stomach cancer	1.67e-05	0.000127	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—TYMS—stomach cancer	1.57e-05	0.00012	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTM1—stomach cancer	1.55e-05	0.000118	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTT1—stomach cancer	1.5e-05	0.000115	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.49e-05	0.000113	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PPARG—stomach cancer	1.48e-05	0.000112	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ERCC2—stomach cancer	1.46e-05	0.000111	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.45e-05	0.00011	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ENO1—stomach cancer	1.41e-05	0.000107	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—MTHFR—stomach cancer	1.37e-05	0.000105	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALB—stomach cancer	1.33e-05	0.000101	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NOS3—stomach cancer	1.27e-05	9.67e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CAV1—stomach cancer	1.27e-05	9.65e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—APOA1—stomach cancer	1.26e-05	9.63e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CD44—stomach cancer	1.25e-05	9.52e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PTGS2—stomach cancer	1.16e-05	8.85e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PPARG—stomach cancer	1.11e-05	8.49e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPP2R1A—stomach cancer	1.06e-05	8.09e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTP1—stomach cancer	1.04e-05	7.94e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HMOX1—stomach cancer	1.03e-05	7.83e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALB—stomach cancer	1e-05	7.63e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—TYMS—stomach cancer	9.69e-06	7.38e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NOS3—stomach cancer	9.58e-06	7.3e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTM1—stomach cancer	9.58e-06	7.3e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ERCC2—stomach cancer	9e-06	6.86e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PTGS2—stomach cancer	8.76e-06	6.68e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—MTHFR—stomach cancer	8.46e-06	6.45e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CAV1—stomach cancer	7.81e-06	5.95e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APOA1—stomach cancer	7.79e-06	5.93e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PIK3CA—stomach cancer	7.14e-06	5.44e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPARG—stomach cancer	6.86e-06	5.23e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALB—stomach cancer	6.17e-06	4.7e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NOS3—stomach cancer	5.9e-06	4.5e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PTGS2—stomach cancer	5.4e-06	4.11e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PIK3CA—stomach cancer	5.39e-06	4.11e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PIK3CA—stomach cancer	3.32e-06	2.53e-05	CbGpPWpGaD
